Xeltis
Series BXeltis raised €27M in a Series B round in Dec 2014. The company is based in Zurich, Switzerland. Investors in the round: Life Sciences Partners, VI Partners. Data as of Nov 2026.
Amount raised
€27M
€27,237,042
Native amount
34,000,000 USD
Stage
Series B
series b
Investors
2
Provenance & confidence
UnverifiedAmount
34,000,000 USD
ECB-at-date → €27M · rate 1.2483 on 2014-11-28
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Dec 2014
Round type
series b
Amount (EUR)
€27M
Related news
- Dutch-Swiss medtech firm Xeltis lands €15M from EIB for its restorative approach in cardiovascular therapysiliconcanals.com · 2021-11